{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:10:53Z","timestamp":1785244253772,"version":"3.55.0"},"reference-count":32,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,5,26]],"date-time":"2010-05-26T00:00:00Z","timestamp":1274832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Mantle cell lymphoma (MCL) has a poor overall survival after treatment with conventional chemotherapy. Intense chemoimmunotherapy without consolidation stem cell transplantation is a potential therapeutic option. We report on a prospective Phase II study with rituximab in combination with fractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone (R\u2010Hyper\u2010CVAD) alternating with rituximab in combination with high\u2010dose methotrexate\u2010cytarabine (R\u2010MA) in untreated patients with diffuse and nodular MCL and their blastoid variants. Ninety\u2010seven patients were treated, of whom 97% responded and 87% achieved a complete remission. At 10\u2003years of follow up (median 8\u2003years), the median overall survival (OS) for all patients had not been reached and the median time to failure (TTF) for all patients was 4.6\u2003years, without a plateau in the curves. For the group of patients aged 65\u2003years or younger, the median OS had not been reached and the median TTF was 5.9\u2003years. Multivariate analysis revealed pre\u2010treatment serum levels of \u03b2<jats:sub>2<\/jats:sub> microglobulin, International Prognostic Index (IPI) score and mantle cell IPI (MIPI) score, as predictive of both OS and TTF. We conclude that intense chemoimmunotherapy without stem cell transplantation is effective for untreated aggressive MCL.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2010.08228.x","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T03:47:04Z","timestamp":1274932024000},"page":"200-208","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":201,"title":["Ten\u2010year follow\u2010up after intense chemoimmunotherapy with Rituximab\u2010HyperCVAD alternating with Rituximab\u2010high dose methotrexate\/cytarabine (R\u2010MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma"],"prefix":"10.1111","volume":"150","author":[{"given":"Jorge E.","family":"Romaguera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E.","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Hartig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alma","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrick B.","family":"Hagemeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Younes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Samaniego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Goy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Cabanillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagop","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,7]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.3116"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.4.1244"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1182\/blood.V86.6.2091.bloodjournal8662091","article-title":"The value of high\u2010dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia","volume":"15","author":"Cortes J.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_5_1","first-page":"425","article-title":"Rituximab and DHAP followed by intensive therapy with autologous stem\u2010cell transplantation as first\u2010line therapy for mantle cell lymphoma","volume":"91","author":"De Guibert S.","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_6_6_1","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V112.11.581.581","article-title":"RCHOP and RDHAP followed by autologous stem cell transplantation (ASCT) in mantle cell lymphoma (MCL): final results of a phase II study from the GELA","volume":"112","author":"Delarue R.","year":"2008","journal-title":"Blood"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-117010"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-10-3883"},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V110.11.387.387","article-title":"A multi center trial of hypercvad+rituxan in patients with newly diagnosed mantle cell lymphoma","volume":"110","author":"Epner E.M.","year":"2007","journal-title":"Blood"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06908.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2007.s.034"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24141"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-147025"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2000.00895.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.8435"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-095331"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl127"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_6_19_1","first-page":"1275","article-title":"Sequential chemotherapy regimens followed by high\u2010dose therapy with stem cell transplantation in mantle cell lymphoma: an update of a prospective study","volume":"89","author":"Lefr\u00e8re F.","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.349"},{"key":"e_1_2_6_21_1","first-page":"1664","article-title":"Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants","volume":"15","author":"Majlis A.","year":"1997","journal-title":"Journal of Oncology"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.6121"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.2307\/2344317"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-07-2845"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-006-0193-2"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.1825"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-184200"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21313"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04140.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07498.x"},{"key":"e_1_2_6_32_1","first-page":"1580","article-title":"High\u2010dose therapy with autologous stem cell transplantation in first response in mantle cell lymphoma","volume":"90","author":"Vigouroux S.","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_6_33_1","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1200\/jco.2006.24.18_suppl.7511","article-title":"Mantle cell lymphoma (MCL): Induction therapy with HyperCVAD\/High\u2010dose methotrexate and cytarabine (M\u2010C) (\u00b1rituximab) improves results of autologous stem cell transplant in first remission","volume":"24","author":"Vose J.","year":"2006","journal-title":"Journal of Clinical Oncology"}],"updated-by":[{"DOI":"10.1111\/j.1365-2141.2010.08392.x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2010,9,29]],"date-time":"2010-09-29T00:00:00Z","timestamp":1285718400000}}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2010.08228.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2010.08228.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T22:44:04Z","timestamp":1697409844000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2010.08228.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1111\/j.1365-2141.2010.08228.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08228.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"2010-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}